Clara Bueno Uroz-rekin lankidetzan egindako argitalpenak (9)

2023

  1. A human genome editing–based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features

    Blood, Vol. 142, Núm. 20, pp. 1752-1756

2022

  1. The insecticides permethrin and chlorpyrifos show limited genotoxicity and no leukemogenic potential in human and murine hematopoietic stem progenitor cells

    Haematologica

2020

  1. Impaired condensin complex and Aurora B kinase underlie mitotic and chromosomal defects in hyperdiploid B-cell ALL

    Blood, Vol. 136, Núm. 3, pp. 313-327

  2. In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells

    Nature Communications, Vol. 11, Núm. 1

  3. Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem Cells

    Molecular Therapy - Nucleic Acids, Vol. 20, pp. 196-204

2017

  1. Efficient Recreation of t(11;22) EWSR1-FLI1+ in Human Stem Cells Using CRISPR/Cas9

    Stem Cell Reports, Vol. 8, Núm. 5, pp. 1408-1420

  2. Generation and characterization of a human iPSC cell line expressing inducible Cas9 in the “safe harbor” AAVS1 locus

    Stem Cell Research, Vol. 21, pp. 137-140

  3. Modeling mixed-lineage-rearranged leukemia initiation in CD34+ cells: A “CRISPR” solution

    Haematologica

2016

  1. Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency

    Stem Cell Reports, Vol. 7, Núm. 4, pp. 602-618